Results 1 to 10 of about 156,393 (161)
COVID‐19 and Oncology: Service transformation during pandemic [PDF]
Cancer Medicine, 2020 Background The COVID‐19 pandemic has challenged healthcare systems around the world, where resources have refocused on increasing critical bed capacity to prepare for the peak in incidence of COVID‐19.
Marco Shiu Tsun Leung +3 more
doaj +3 more sources
A novel cardio-oncology service line model in optimizing care access, quality and equity for large, multi-hospital health systems [PDF]
Cardio-Oncology, 2023 Background Despite the rapid growth of cardio-oncology as a subspecialty, cancer patients are still underserved from a cardiovascular perspective. A new care model is needed to integrate comprehensive cardio-oncology care with community-based facilities ...
Yan Liu
doaj +2 more sources
Perceptions of the Cardiologists and Oncologists: Initial Step for Establishing Cardio-Oncology Service [PDF]
Frontiers in Cardiovascular Medicine, 2021 Background: Over the last years, there was no established cardio-oncology service in Iraq and no firm data about the incidence of cardiovascular disease (CVD) among patients with cancer.
Hasan Ali Farhan +2 more
doaj +2 more sources
Medical education on inpatient medical oncology service before and after oncology hospitalist program [PDF]
BMC Medical EducationBackground At Smilow Cancer Hospital, internal medicine-boarded oncology hospitalists assumed primary team attending responsibilities on an adult inpatient medical oncology academic service beginning in 2021.
Ronald Chow +10 more
doaj +2 more sources
Interventional Oncology Service Development. [PDF]
Semin Intervent Radiol, 2017 AbstractInterventional oncology is rapidly expanding its suite of oncologic therapies, providing unique proven therapeutic benefits. To grow a practice alongside other oncology specialties, knowledge of cancer fundamentals is required. Areas of interest include methods to assess disease stage, treatment toxicity, and response.
Mouli S, Baker JC, Brown DB.
europepmc +4 more sources
Frontiers in Oncology, 2023 IntroductionThe global cancer burden has been disproportionately shifting towards low- and middle-income countries (LMICs). Limited availability and accessibility to screening, treatment and surveillance, increase in the prevalence and lack of control of
Mouness Obeidat +11 more
doaj +1 more source
Cancer Medicine, 2023 Background While patient‐reported outcome measures (PROMs) have benefit in cancer clinical trials, real‐world applications are lacking. This study describes the method of implementation of a cancer enterprise‐wide PROMs platform.
Samantha Tam +9 more
doaj +1 more source
Journal of Applied Hematology, 2021 BACKGROUND: Coronavirus disease 2019 (COVID-19) pandemic has caused disruption of oncology services, but data on actual delays are lacking. We sought to study the delays faced by the cancer patients during the COVID-19 pandemic and the impact of measures
Khalid AlSaleh
doaj +1 more source
Frontiers in Public Health, 2023 ObjectiveTo evaluate the impact of the COVID-19 pandemic on first and follow-up visits for cancer outpatients.MethodsThis is a multicenter retrospective observational study involving three Comprehensive Cancer Care Centers (CCCCs): IFO, including IRE and
Vincenza Frisardi +17 more
doaj +1 more source
Quantifying the impact of the COVID‐19 pandemic on gastrointestinal cancer care delivery
Cancer Reports, 2022 Background and Aim This study quantifies how changes in healthcare utilization and delivery during the first months of the COVID‐19 pandemic have altered the presentation, treatment, and management of patients with gastrointestinal (GI) malignancies ...
Nicholas R. Perkons +10 more
doaj +1 more source